Radioactive seeds implanted during surgery show promise for recurrent head and neck cancer
NCT ID NCT02467738
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tested a new approach for people whose head and neck cancer has come back. During surgery to remove the tumor, doctors placed tiny radioactive seeds (Cesium-131) directly into the area to kill any remaining cancer cells. The goal was to see if this internal radiation could help prevent the cancer from returning and improve survival. The study involved 30 adults with resectable recurrent head and neck cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT HEAD AND NECK CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.